Previous Close | $104.57 |
Intrinsic Value | $21.49 |
Upside potential | -79% |
Data is not available at this time.
Aflac Incorporated operates as a leading provider of supplemental health and life insurance, primarily in the U.S. and Japan. The company’s core revenue model revolves around underwriting insurance policies, with a strong emphasis on cancer, medical, and income protection products. Aflac’s brand recognition, particularly through its iconic duck mascot, reinforces its market position as a trusted name in voluntary insurance. In Japan, its largest market, Aflac dominates the supplemental health insurance space, leveraging long-standing relationships and a deep understanding of local consumer needs. The U.S. segment focuses on worksite marketing, partnering with employers to offer voluntary benefits. Aflac’s competitive edge lies in its efficient claims processing, high customer retention, and ability to cross-sell products. The company’s disciplined underwriting and conservative investment approach further solidify its reputation for financial stability in the insurance sector.
Aflac reported $19.1 billion in revenue for FY 2024, with net income of $5.4 billion, reflecting a robust profit margin of approximately 28.5%. The company’s diluted EPS stood at $9.63, demonstrating strong earnings power. Operating cash flow was $2.7 billion, indicating efficient cash generation from core operations. Notably, Aflac’s capital expenditures were negligible, underscoring its asset-light business model and focus on underwriting profitability.
Aflac’s earnings power is driven by its disciplined underwriting and investment income, with a high return on equity supported by its capital-efficient model. The company’s ability to generate consistent cash flows allows for strategic reinvestment and shareholder returns. Its capital allocation prioritizes maintaining strong reserves, funding growth initiatives, and returning excess capital through dividends and share repurchases.
Aflac maintains a solid balance sheet with $6.2 billion in cash and equivalents and $7.5 billion in total debt, reflecting a conservative leverage profile. The company’s financial health is further reinforced by its strong liquidity position and investment-grade credit ratings, ensuring flexibility to navigate market volatility and meet policyholder obligations.
Aflac has demonstrated steady growth in its core markets, with a focus on expanding its product portfolio and digital capabilities. The company’s dividend policy is shareholder-friendly, with a dividend per share of $1.95 in FY 2024, supported by its stable cash flows and commitment to returning capital to investors.
Aflac’s valuation reflects its stable earnings, strong market position, and consistent dividend payouts. The market appears to price in moderate growth expectations, with a focus on the company’s ability to maintain underwriting discipline and capitalize on opportunities in its key markets.
Aflac’s strategic advantages include its strong brand, diversified product offerings, and deep market penetration in Japan and the U.S. The outlook remains positive, with opportunities for growth in digital transformation and expanding its reach in underserved markets. The company’s conservative financial management and focus on long-term sustainability position it well for continued success.
10-K, investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |